TUI, BA share prices soar on US vaccine news
Shares in TUI UK, International Airlines Group and EasyJet have soared on news that an experimental drug in the US has been 90% effective in trials.
IAG’s stock jumped more than 35% in trading today with EasyJet up 30% and TUI rising 23%. Ryanair showed a more modest jump of 12%.
The spikes follow an announcement by Pfizer/BioNTech that interim results of a large-scale trial have performed far better than experts had hoped.
The pharmaceutical giant claimed trials were 90% effective, adding there were no serious side effects.
Regulators have previously said they would approve a vaccine even if it was only 50% effective.
The results have buoyed the travel sector and given renewed hope that a full roll out of a Covid vaccine could arrive sooner than expected.
"Today is a great day for science and humanity. The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19," Pfizer Chairman and CEO Dr Albert Bourla said.
"We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen."
Airline share prices around the world have been hammered since Covid took hold in March.
Dozens fall ill in P&O Cruises ship outbreak
Turkish Airlines flight in emergency landing after pilot dies
Boy falls to death on cruise ship
Unexpected wave rocks cruise ship
Woman dies after going overboard in English Channel